Client was about to lose exclusivity of several biological compounds
Our Intervention :
Based on historical data we developed a new segmentation and strategy to identify client we could not retain/clients we will keep no matter what/clients on the take and action to retain them
Furthermore, we identify the time it will take them to convert to prioritize.
Added value :
A new strategy which decrease impacts on sales after biosimilar entry